Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/10/2019
SIETES contiene 92824 citas

 
 
 1 a 19 de 19 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
2.Enlace a cita original Cita con resumen
Anónimo. Riesgos de los AINE en pacientes que reciben tratamiento antitrombótico. Butlletí Groc 2015;28:5-10. [Ref.ID 99839]
3. Cita con resumen
Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen H, Larsen TB, Lip GYH. Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. JAMA 2015;314:8 de septiembre. [Ref.ID 99418]
4. Cita con resumen
Hsu JC, Chan PS, Tang F, Maddox TM, Marcus GM. Oral anticoagulant prescription in patients with atrial fibrillation and a low risk of thromboembolism: insights from the NCDR PINNACLE registry. JAMA Intern Med 2015;175:1062-5. [Ref.ID 99111]
5.Tiene citas relacionadas Cita con resumen
Chao TF, Liu CJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen TJ, Lip GY, Chen SA. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?. J Am Coll Cardiol 2015;65:635-42. [Ref.ID 99046]
6.Tiene citas relacionadas Cita con resumen
Singer DE, Ezekowitz MD. Adding rigor to stroke risk prediction in atrial fibrillation. J Am Coll Cardiol 2015;65:233-5. [Ref.ID 99045]
7.Tiene citas relacionadas Cita con resumen
Friberg L, Skeppholm M, Terént A. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J Am Coll Cardiol 2015;65:225-32. [Ref.ID 99044]
8.Tiene citas relacionadas Cita con resumen
Fleischmann KE. Should we anticoagulate patients with CHA2DS2-VASc scores of 1? . Journal Watch 2015:7 de mayo. [Ref.ID 99040]
9. Cita con resumen
O'Brien EC, Kim S, Hess PL, Kowey PR, Fonarow GC, Piccini JP, Peterson ED. Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulation. JAMA Intern Med 2015;175:848-50. [Ref.ID 98945]
10. Cita con resumen
Lip GYH, Skjoth F, Rasmussen LH, Larsen TB. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. J Am Coll Cardiol 2015;65:1385-94. [Ref.ID 98892]
12.Enlace a cita original Cita con resumen
Forslund T, Wettermark B, Wändell P, von Euler M, Hasselström J, Hjemdahl P. Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CH2DS2VASc scores: experience from the Stockholm region. Eur J Clin Pharmacol 2014;70:1477-85. [Ref.ID 98416]
13.Tiene citas relacionadas
Jones C, Pollit V, Fitzmaurice D, Cowan C, on behalf of the Guideline Development Group. The management of atrial fibrillation: summary of updated NICE guidance. BMJ 2014;348:g3655. [Ref.ID 98055]
14. Cita con resumen
Anónimo. Treatment of atrial fibrillation. Med Lett Drugs Ther 2014;56:53-8. [Ref.ID 97926]
16.Tiene citas relacionadas Cita con resumen
Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, Vicente V, Lip GYH. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real world" population with atrial fibrillation receiving anticoagulant therapy. Chest 2013;143:179-84. [Ref.ID 94638]
17.Tiene citas relacionadas Cita con resumen
Donzé J, Rodondi N, Waeber G, Monney P, Cornuz J, Aujesky D. Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study. Am J Med 2012;125:1095-102. [Ref.ID 93713]
19.Tiene citas relacionadas
Oldgren J, Alings M, Darius H, Diener H-C, Eikelboom J, Ezekowitz MD, Kamensky G, Reilly PA, Yang S, Yusuf S, Wallentin L, Connolly SJ, on behalf of the RE-LY investigators. Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial. Ann Intern Med 2011;155:660-7. [Ref.ID 91630]
Seleccionar todas
 
 1 a 19 de 19